Singapore firm comes up with world’s first molecular blood test for early detection of gastric cancer


Associate Professor Too Heng-Phon, co-founder of Mirxes, which developed the test kit for early detection of gastric cancer. - The Straits Times/ANN

SINGAPORE, Nov 27 (The Straits Times/ANN): When Associate Professor Too Heng-Phon was about to start biotech firm Mirxes back in 2010, he asked several of his PhD students to join him, but also warned them that it would be tough going.

Two of them decided to help set up the home-grown biotechnology firm, which went on to develop test kits that use blood-based microRNAs (miRNAs) to serve as biomarkers for early detection of cancers.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Singapore , Gastric Cancer , Research

Next In Aseanplus News

New bridge inaugurated to boost Laos–Thailand–Vietnam trade connectivity
Momota shows flashes of his old brilliance at King's Cup
Four Spaniards missing after wooden tourist boat sinks off Indonesia's famous Komodo National Park
Hong Kong star Miriam Yeung spends Christmas holiday in 'super hot spot' Penang
Elderly woman forced to evacuate home three times in a month due to floods
Two names submitted for Perlis MB post
Muhyiddin says Bersatu name submitted for Perlis MB post, had no hand in SDs
Cricket-Stokes savours the end of England's victory drought in Australia
Indonesian maritime patrol vessel arrives in North Aceh with 92.2 tonnes of aid
To protect deminers, Cambodia suspends clearance operations

Others Also Read